Physician

Darmakusuma Ie, M.D.

According to 2025 Medicare claims, Darmakusuma Ie, M.D. (NPI: 1881690956) practices ophthalmology in the Montgomery County-Bucks County-Chester County, PA market, with the plurality of this provider's patient population coming from Bucks, PA. This provider's primary affiliated billing organization is ASSOCIATED RETINAL CONSULTANTS LLC (NPI: 1164578894; TIN: 208346981) and primary practice location at 18901-5843. Ie is affiliated with the Physician Leaders Direct Contracting Entity, LLC (ACO ID: D0171) and Vytalize Health 9 ACO LLC (ACO ID: D0313), participating under the REACH model.

Ie's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,386 traditional Medicare patients, billed 26,917 HCPCS/CPT codes, and received $3,670,665 in Medicare payments. The top billing code was 92014 (Established patient complete exam of visual system). Part D data shows 368 prescription claims across 123 beneficiaries totaling $30,393 in drug costs, led by Bromfenac Sodium (Bromfenac Sodium). Open Payments data shows 1 records totaling $111. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $16,675 to $30,393. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,132	10,747	$1,815,990
2016	1,189	11,317	$1,776,531
2017	1,080	9,385	$1,568,541
2018	1,101	10,601	$1,719,425
2019	1,064	10,803	$1,689,198
2020	907	8,974	$1,506,091
2021	987	10,422	$1,857,421
2022	1,039	10,806	$1,759,270
2023	1,256	16,215	$2,116,154
2024	1,386	26,917	$3,670,665

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	41	125	$16,675
2016	41	147	$17,717
2017	37	133	$15,267
2018	41	114	$13,752
2019	45	176	$33,559
2020	49	182	$32,584
2021	61	236	$37,043
2022	76	285	$35,545
2023	84	352	$33,187
2024	123	368	$30,393

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
92014	Established patient complete exam of visual system	1,289	3,074	$106
67028	Injection of drug into eye	351	2,080	$100
92134	Imaging of retina	1,152	3,004	$35
92201	Extended exam of the back part of the eye with retinal drawing	777	890	$20
92202	Extended exam of the back part of the eye with optic nerve drawing	696	888	$14

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Bromfenac Sodium	Bromfenac Sodium	33	1,270	$7,423
Prolensa	Bromfenac Sodium	17	708	$6,804
Prednisolone Acetate	Prednisolone Acetate	118	4,337	$4,616
Loteprednol Etabonate	Loteprednol Etabonate	17	788	$3,854
Ketorolac Tromethamine	Ketorolac Tromethamine	35	1,224	$1,687

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$111	Regeneron Healthcare Solutions, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Darmakusuma Ie, M.D.?

Tedicare shows public-source Medicare data for Darmakusuma Ie, M.D. (NPI 1881690956), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Darmakusuma Ie, M.D. have ACO affiliation data?

Darmakusuma Ie, M.D. is shown with ACO affiliation data for Physician Leaders Direct Contracting Entity, LLC (REACH, ACO ID D0171) and Vytalize Health 9 ACO LLC (REACH, ACO ID D0313).

What billing organization is linked to Darmakusuma Ie, M.D.?

Darmakusuma Ie, M.D. is linked to ASSOCIATED RETINAL CONSULTANTS LLC (billing NPI 1164578894) in the available physician profile data.

Does Darmakusuma Ie, M.D. have Open Payments data?

Darmakusuma Ie, M.D. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.